The Centers for Medicare and Medicaid Services (CMS) has set an aggressive goal that by the year 2030 all Medicare beneficiaries with Parts A and B will be in a care relationship with ...
The Food and Drug Administration (FDA) Breakthrough Devices Program was created by the Congress in the 21st Century Cures Act of 2016. The program is designed to accelerate the development ...
In January 2023, legislation was filed in Massachusetts (Bill S.750) that aims to improve health and reduce health inequities by doubling primary care investment in the state. S.750 was referred ...
Given the dangerous consequences of system failure, health care leaders must support programs and systems that focus on resiliency and continuity planning to mitigate these hazards.
The immediate aftermath of the 2024 presidential election has brought renewed attention to regulatory policy at the U.S. Food and Drug Administration (FDA). One cause is Robert F. Kennedy, Jr.